Progressive Care Inc. Announces April Sales & Record Breaking Month

MIAMI – May 21, 2019 – Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of prescriptions filled for April 2019 and a record month for PharmCo revenue in Palm Beach,which increased at 100%.

In April, the company reported a total of $1.935 million in net revenue, a 17% increase from the same month last year, and a 30% increase in prescriptions filled during the same month last year, totaling nearly 28,725 prescriptions filled. Both PharmCo locations had 15% growth in prescription counts compared to April last year. 

“Progressive Care’s April sales and prescription numbers are directly attributed to increased sales derived from marketing activities promoting risk management, medication adherence management, and superior pharmacy performance metrics to Physicians Practices and Management Services Organizations ,” said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. “We are confident that our company will continue to grow with more record-breaking months by providing our customers with top-quality healthcare management services.”

For more information about Progressive Care, please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc.

https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care Inc.

Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward-Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Investor Relations Contact:

Armen Karapetyan, Progressive Care

Senior Advisor Business Development

Armen@progressivecareus.com

www.progressivecareus.com

www.pharmcopharmacy.com

Public Relations Contact:

Kathleen Gonzales, CMW Media

Kathleen@cmwmedia.com

www.cmwmedia.com

Web and Application Development Contact:

Marcello Jaspan, Mass Ventures Corp

Marcello@massventurescorp.com

www.massventurescorp.com

Leave a Reply

Your email address will not be published. Required fields are marked *